Xylem Total Cost of Revenue decreased by 9.8% to $1.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.6%, from $1.30B to $1.32B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 14.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $831.00M | $793.00M | $830.00M | $805.00M | $844.00M | $856.00M | $933.00M | $902.00M | $1.07B | $1.31B | $1.36B | $1.28B | $1.35B | $1.32B | $1.40B | $1.30B | $1.41B | $1.39B | $1.47B | $1.32B |
| QoQ Change | — | -4.6% | +4.7% | -3.0% | +4.8% | +1.4% | +9.0% | -3.3% | +18.7% | +22.5% | +3.8% | -5.9% | +5.4% | -2.2% | +6.0% | -7.0% | +8.3% | -1.7% | +5.8% | -9.8% |
| YoY Change | — | — | — | — | +1.6% | +7.9% | +12.4% | +12.0% | +26.9% | +53.3% | +46.0% | +42.0% | +26.1% | +0.6% | +2.7% | +1.6% | +4.4% | +4.9% | +4.7% | +1.6% |
| Segment | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|
| Water Infrastructure | $365.00M | $357.00M | $333.00M |
| Measurement and Control Solutions | $324.00M | $322.00M | $317.00M |
| Applied Water | $299.00M | $291.00M | $285.00M |
| Total | $1.41B | $1.39B | $1.32B |